My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Growth Regul. 1991 Dec;1(4):153-9.

    24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment.

    Nielsen HK, Jørgensen JO, Brixen K, Møller N, Charles P, Christensen JS.

    University Department of Medical Endocrinology and Metabolism, Aarhus Amtssygehus, Denmark.

    Serum osteocalcin (OC), which is a specific, sensitive, and rapidly responding biochemical bone marker of osteoblastic activity, varies in a circadian rhythm in both normal adults and children with the highest levels during nighttime. In the present study, we characterized the 24-h rhythm of serum OC in 8 growth hormone (GH)-deficient children without treatment, and during two regimens of recombinant human GH (r-hGH), i.e. 2 IU/day s.c. at 08:00 h or at 20:00 h, in comparison with 5 normal, untreated children. Without treatment and when r-hGH was administered at 08:00 h, the 24-h profile of serum OC was correlated with that of the healthy controls in only 1 of 8 patients (r = 0.26 +/- 0.09 (mean +/- SE) and r = 0.10 +/- 0.08) whereas the correlation was significant in 6 of 8 patients (r = 0.44 +/- 0.05) during evening r-hGH administration. Within GH-deficient patients, mean OC level was lower during no r-hGH or evening administration compared with morning administration. In conclusion, untreated GH-deficient children have an abnormal 24-h serum OC profile. Evening administration of 2 IU of r-hGH/day s.c. tends to normalise the 24-h profile but not the average daily level, whereas morning administration of GH increases average daily OC level but does not normalize the circadian rhythm.

    PMID: 1842347 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Write to the Help Desk